See more : China First Heavy Industries (601106.SS) Income Statement Analysis – Financial Results
Complete financial analysis of Nano-X Imaging Ltd. (NNOX) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Nano-X Imaging Ltd., a leading company in the Medical – Devices industry within the Healthcare sector.
- Knife River Corporation (KNF) Income Statement Analysis – Financial Results
- Atlantic Sapphire ASA (AASZF) Income Statement Analysis – Financial Results
- KITO Corporation (6409.T) Income Statement Analysis – Financial Results
- The Southern Company (SO) Income Statement Analysis – Financial Results
- Doma Holdings Inc. (DOMA-WT) Income Statement Analysis – Financial Results
Nano-X Imaging Ltd. (NNOX)
About Nano-X Imaging Ltd.
Nano-X Imaging Ltd. develops a commercial-grade tomographic imaging device with a digital X-ray source. The company provides teleradiology services and develops artificial intelligence applications to be used in real-world medical imaging applications. Its X-ray source is based on a digital micro-electro-mechanical systems semiconductor cathode. The company develops a prototype of the Nanox.ARC, a medical imaging system incorporating its digital X-ray source; and Nanox.CLOUD, a companion cloud-based software that would allow for the delivery of medical screening as a service. It also offers Nanox.MARKETPLACE, which connects imaging facilities with radiologists and enables radiologists to provide, as well as customers to obtain remote interpretations of imaging data; artificial intelligence (AI)-based software imaging solutions to hospitals, health maintenance organizations, integrated delivery networks, pharmaceutical companies, and insurers that are designed to identify or predict undiagnosed or underdiagnosed medical conditions through the mining of data included in images of existing computed tomography scans for osteoporosis and cardiovascular disease; Teleradiology Services, which provide imaging interpretation services for radiology practices, hospitals, medical clinics, diagnostic imaging centers, urgent care facilities; and multi-specialty physician groups, contracts, and radiology readings. The company was founded in 2011 and is headquartered in Neve Ilan, Israel.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Revenue | 9.91M | 8.58M | 1.30M | 0.00 | 0.00 | 0.00 |
Cost of Revenue | 16.50M | 15.46M | 2.82M | 208.00K | 53.00K | 35.00K |
Gross Profit | -6.59M | -6.88M | -1.51M | -208.00K | -53.00K | -35.00K |
Gross Profit Ratio | -66.55% | -80.21% | -115.95% | 0.00% | 0.00% | 0.00% |
Research & Development | 26.05M | 26.51M | 17.12M | 9.21M | 2.72M | 672.00K |
General & Administrative | 26.01M | 41.25M | 34.71M | 22.27M | 18.30M | 1.02M |
Selling & Marketing | 2.38M | 4.38M | 7.03M | 12.45M | 1.56M | 209.00K |
SG&A | 28.39M | 45.63M | 41.74M | 34.71M | 19.85M | 1.23M |
Other Expenses | 1.55M | 191.00K | 1.18M | 0.00 | 0.00 | 0.00 |
Operating Expenses | 56.00M | 72.33M | 60.05M | 43.92M | 22.57M | 1.90M |
Cost & Expenses | 72.49M | 87.79M | 62.86M | 43.92M | 22.57M | 1.90M |
Interest Income | 1.65M | 789.00K | 288.00K | 108.00K | 8.00K | 0.00 |
Interest Expense | 0.00 | 60.22M | 288.00K | 0.00 | 0.00 | 5.00K |
Depreciation & Amortization | 11.81M | 11.51M | 2.29M | 208.00K | 53.00K | 35.00K |
EBITDA | -47.69M | -75.70M | -59.27M | -43.61M | -22.52M | -1.87M |
EBITDA Ratio | -481.50% | -433.60% | -4,720.71% | 0.00% | 0.00% | 0.00% |
Operating Income | -62.59M | -109.71M | -61.56M | -43.92M | -22.57M | -1.90M |
Operating Income Ratio | -631.89% | -1,278.97% | -4,720.71% | 0.00% | 0.00% | 0.00% |
Total Other Income/Expenses | 1.47M | -14.67M | -288.00K | 108.00K | 8.00K | -5.00K |
Income Before Tax | -61.12M | -108.92M | -61.85M | -43.82M | -22.56M | -1.91M |
Income Before Tax Ratio | -617.01% | -1,269.77% | -4,742.79% | 0.00% | 0.00% | 0.00% |
Income Tax Expense | -339.00K | -3.68M | -48.00K | -316.00K | -8.00K | 5.00K |
Net Income | -60.78M | -105.24M | -61.80M | -43.50M | -22.56M | -1.91M |
Net Income Ratio | -613.59% | -1,226.89% | -4,739.11% | 0.00% | 0.00% | 0.00% |
EPS | -1.08 | -2.01 | -1.28 | -1.22 | -0.49 | -0.06 |
EPS Diluted | -1.08 | -2.01 | -1.28 | -1.22 | -0.49 | -0.06 |
Weighted Avg Shares Out | 56.37M | 52.24M | 48.22M | 35.65M | 45.72M | 34.17M |
Weighted Avg Shares Out (Dil) | 56.37M | 52.24M | 48.22M | 35.65M | 45.72M | 34.17M |
These 2 Growth Stocks Already Doubled, and There's More Upside, According to Wall Street
If You Own These 3 Growth Stocks, You Might Want to Rethink Your Position
Why Nanox Stock Skyrocketed 191% in May
Nano-X Imaging Ltd. (NNOX) Just Reclaimed the 20-Day Moving Average
Is It Too Early to Invest In Nano-X Imaging?
Why Shares of Nano-X Are Soaring Wednesday
2 Growth Stocks That Doubled in 2023 and Could Shoot 55% to 87% Higher, According to Wall Street
Why Nanox Stock Popped Off Another Huge Gain Today
Nanox Announces First Quarter of 2023 Financial Results and Provides Business Update
Nanox to Report First Quarter 2023 Financial Results on May 22, 2023
Source: https://incomestatements.info
Category: Stock Reports